Vertex Pharmaceuticals reports 2Q loss
BOSTON — Vertex Pharmaceuticals Inc. (VRTX) on Wednesday reported a loss of $64.5 million in its second quarter. The Boston-based company said it had a loss of 26 cents per share. Earnings, adjusted for stock option expense and non-recurring costs, came to 24 cents per share. The results exceeded Wall Street expectations. The average estimate